Home / Companies / Sun Pharmaceutical Industries Limited / 31 Jul 2025
Sun Pharmaceutical Industries Limited: meeting of 31 Jul 2025
Votes reported on Form N-PX, item by item
82 Form N-PX filers reported votes at the Sun Pharmaceutical Industries Limited meeting of 31 Jul 2025. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
150 vote records from 81 filers. 1 of the 80 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
149 vote records from 81 filers. 0 of the 80 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
421 vote records from 74 filers. 3 of the 73 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
430 vote records from 81 filers. 0 of the 80 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
47 vote records from 8 filers. 0 of the 8 filers that marked the item either way voted against management.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
4 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Auditor |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | For |
| State Street and SPDR | For |
| American Century | For |
| Franklin Templeton | For |
| Invesco | For |
| Equitable | Abstain or withhold * |
| Nuveen and TIAA | For |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| J.P. Morgan | For |
| Goldman Sachs | For |
| WisdomTree | For |
| PGIM and Prudential | For |
| Jackson National funds | For |
| Northern Trust and FlexShares | For |
| Lincoln Financial | For |
| Voya | For |
| First Trust | For |
| Nationwide | For |
| Victory Capital | For |
| Brighthouse Funds | For |
| Columbia Threadneedle | For |
| BNY Mellon | For |
| Pacific Life funds | For |
| MFS | For |
| PIMCO | For |
| Macquarie and Delaware Funds | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Sun Pharmaceutical Industries Limited meeting?
82 Form N-PX filers reported votes at the meeting of 31 Jul 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sun Pharmaceutical Industries Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Sun Pharmaceutical Industries Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sun Pharmaceutical Industries Limited with a meeting date within three days of 31 Jul 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.